TTNP - タイタン・ファ―マシュ―ティカルズ （Titan Pharmaceuticals Inc.）

There are two main reasons why moving averages are useful in forex trading: moving averages help traders define trend recognize changes in trend. Now well have a look on, SMA50 … The post Simple Rule To have an eye on this stocks: Aytu BioPharma, Inc. (NASDAQ:AYTU -0.24%), Titan Pharmaceuticals, Inc. (NASDAQ:TTNP -0.69%) appeared first on Stocks Equity .

Titan Pharmaceuticals Inc. (NASDAQ:TTNP) shares, rose in value on Friday, 08/05/22, with the stock price up by 0.69% to the previous day’s close as strong demand from buyers drove the stock to $1.46. Actively observing the price movement in the last trading, the stock closed the session at $1.45, falling within a range of $1.43 … Titan Pharmaceuticals Inc. (NASDAQ: TTNP) Surged 0.69%, So What Now? Read More »

Jim Simons and Josh Resnick might not be familiar names to many investors, but both hedge fund managers have beaten the S&P 500 over the past three years.

Gainers Seritage Growth Properties (NYSE: SRG ) shares surged 80.3% to settle at $10.96 after the company appointed Adam Metz as Chairman. Preliminary proxy materials also indicated the board recommended shareholders to approve a proposed plan sale. Aditxt, Inc. (NASDAQ: ADTX ) shares climbed 50% to close at $0.24 on Friday after the company''s Adimune therapeutic program completed a toxicology study indicating a favorable safety profile of ADI-100. Waitr Holdings Inc. (NASDAQ: WTRH ) gained 48.5% to settle at $0.35 after the company announced a new partnership with Burq to allow deliveries from several new retail industries. Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ) surged 44.4% to close at $8.20. MyMD Pharmaceuticals, Inc. (NASDAQ: MYMD ) jumped 42.1% to close at $4.25 after gaining 9% on Thursday. Kura Sushi USA, Inc. (NASDAQ: KRUS ) climbed 33.6% to close at $72.29 after the company reported better-than-expected Q3 EPS and sales results. The company also issued FY22 sales guidance above analyst estimates.

Gainers United Maritime Corporation (NASDAQ: USEA ) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company''s recent listing on the Nasdaq Capital Market. Grove Collaborative Holdings, Inc. (NYSE: GROV ) shares climbed 84.3% to close at $7.37 amid news the company''s products will now be available in Kohl''s (NYSE: KSS ), Midwest-based Meijer and also Giant Eagle. American Rebel Holdings, Inc. (NASDAQ: AREB ) jumped 55.7% to close at $1.19. American Rebel Holdings agreed to acquire Utah-based Champion Safe Company and its ancillary companies, in a transaction valued at $9.9 million. Kiromic BioPharma, Inc. (NASDAQ: KRBP ) surged 43.5% to close at $0.5480. Kiromic BioPharma completed the construction of its expanded current good manufacturing practice manufacturing facility in Houston. AcelRx Pharmaceuticals, Inc. (NASDAQ: ACRX ) jumped 36.2% to close at $0.3529 after gaining around 4% on Wednesday. Dermata Therapeutics, Inc. (NASDAQ: DRMA ) gained 32.7% to settle at $0.6902.

During the last session, Titan Pharmaceuticals Inc. (NASDAQ:TTNP)’s traded shares were 0.54 million, with the beta value of the company hitting 0.37. At the end of the trading day, the stock’s price was $0.59, reflecting an intraday gain of 0.88% or $0.01. The 52-week high for the TTNP share is $3.10, that puts it down … Boom Or Bust: Where Does Titan Pharmaceuticals Inc. (NASDAQ: TTNP) Stock Go From Here? Read More »

Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has a beta value of 0.66 and has seen 1.1 million shares traded in the last trading session. The company, currently valued at $9.14M, closed the last trade at $0.74 per share which meant it lost -$0.02 on the day or -3.69% during that session. The TTNP stock price is -318.92% … -3.69 Fall Turns Titan Pharmaceuticals Inc. (TTNP) Into A Losing Stock For Investors Read More »

Opioids Agonist Drugs market research report is known as a methodical process of collecting and analyzing the information related to consumers, key pricing structure, competitors, market size, company profiles, target market, growth factors. It makes attentive to major players regarding

Titan Pharmaceuticals Inc (NASDAQ: TTNP ) has announced a private placement of 3.37 million shares and 1.29 million pre-funded warrants. In addition, the Company has agreed to issue to the investor unregistered warrants to purchase up to an aggregate of 4.67 million shares. The combined offering price of each share or pre-funded warrant and Full story available on Benzinga.com

Titan Pharmaceuticals (TTNP) trades 3.9% lower premarket after it entered into a securities purchase agreement with a single institutional investor to purchase 3.37M shares in a

Titan Pharmaceuticals Inc. (NASDAQ:TTNP) has a beta value of 0.66 and has seen 1.1 million shares traded in the last trading session. The company, currently valued at $9.14M, closed the last trade at $0.74 per share which meant it lost -$0.02 on the day or -3.69% during that session. The TTNP stock price is -318.92% … -3.69 Fall Turns Titan Pharmaceuticals Inc. (TTNP) Into A Losing Stock For Investors Read More »

Opioids Agonist Drugs market research report is known as a methodical process of collecting and analyzing the information related to consumers, key pricing structure, competitors, market size, company profiles, target market, growth factors. It makes attentive to major players regarding

Titan Pharmaceuticals Inc (NASDAQ: TTNP ) has announced a private placement of 3.37 million shares and 1.29 million pre-funded warrants. In addition, the Company has agreed to issue to the investor unregistered warrants to purchase up to an aggregate of 4.67 million shares. The combined offering price of each share or pre-funded warrant and Full story available on Benzinga.com

Titan Pharmaceuticals (TTNP) trades 3.9% lower premarket after it entered into a securities purchase agreement with a single institutional investor to purchase 3.37M shares in a

In last trading session, Titan Pharmaceuticals Inc. (NASDAQ:TTNP) saw 0.69 million shares changing hands with its beta currently measuring 0.78. Companys recent per share price level of $1.14 trading at -$0.11 or -8.80% at ring of the bell on the day assigns it a market valuation of $11.19M. That closing price of TTNPs stock is Titan Pharmaceuticals Inc. (NASDAQ:TTNP) Shares Rebounded 9.65% From Their Lows But Can They Continue? Read More »